Xyzal: Advanced Relief for Year-Round Allergy Symptoms
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.50 | $50.07 (0%) | 🛒 Add to cart |
| 30 | $2.20 | $75.11 $66.09 (12%) | 🛒 Add to cart |
| 60 | $1.90 | $150.21 $114.16 (24%) | 🛒 Add to cart |
| 90 | $1.60 | $225.32 $144.20 (36%) | 🛒 Add to cart |
| 120 | $1.30 | $300.43 $156.22 (48%) | 🛒 Add to cart |
| 180 | $1.00 | $450.64 $180.26 (60%) | 🛒 Add to cart |
| 270 | $0.80 | $675.96 $216.31 (68%) | 🛒 Add to cart |
| 360 | $0.70
Best per pill | $901.28 $252.36 (72%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.78 | $47.07 (0%) | 🛒 Add to cart |
| 90 | $0.63 | $70.60 $57.08 (19%) | 🛒 Add to cart |
| 120 | $0.53 | $94.13 $64.09 (32%) | 🛒 Add to cart |
| 180 | $0.47 | $141.20 $85.12 (40%) | 🛒 Add to cart |
| 270 | $0.40 | $211.80 $108.15 (49%) | 🛒 Add to cart |
| 360 | $0.35
Best per pill | $282.40 $126.18 (55%) | 🛒 Add to cart |
Synonyms | |||
Xyzal (levocetirizine dihydrochloride) is a prescription-strength, non-drowsy antihistamine designed to provide 24-hour relief from indoor and outdoor allergy symptoms. As the active enantiomer of cetirizine, it offers targeted histamine H1-receptor blockade with a rapid onset of action and sustained efficacy. This second-generation antihistamine minimizes central nervous system penetration, reducing the risk of sedation while maximizing therapeutic benefit for allergic rhinitis and chronic idiopathic urticaria. Its well-established pharmacokinetic profile ensures consistent performance across diverse patient populations.
Features
- Active ingredient: Levocetirizine dihydrochloride 5 mg per tablet
- Pharmacological class: Second-generation selective H1-receptor antagonist
- Duration of action: 24-hour sustained relief with single daily dosing
- Formulation: Film-coated tablets with rapid disintegration properties
- Bioavailability: Approximately 100% with minimal first-pass metabolism
- Protein binding: 91-92% with volume of distribution of 0.4 L/kg
- Half-life: 8-9 hours in adults with normal renal function
- Excretion: Primarily renal (85.4% unchanged drug in urine)
- Storage: Room temperature (15-30°C) in original container
Benefits
- Provides comprehensive relief from nasal and ocular allergy symptoms within one hour of administration
- Maintains continuous 24-hour symptom control with once-daily dosing convenience
- Demonstrates superior efficacy to placebo in reducing Total Symptom Scores (TSS) in seasonal allergic rhinitis trials
- Shows significant improvement in quality of life measures in patients with chronic urticaria
- Exhibits minimal cardiotoxicity risk compared to first-generation antihistamines
- Offers favorable safety profile with low incidence of sedation (6% vs 2% placebo)
Common use
Xyzal is indicated for the relief of symptoms associated with perennial and seasonal allergic rhinitis in adults and children 6 years and older. These symptoms include sneezing, rhinorrhea, pruritus of the nose/palate/throat, ocular itching, and lacrimation. It is also approved for the treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in patients 6 months and older. Clinical studies demonstrate particular efficacy in patients who have shown suboptimal response to other second-generation antihistamines.
Dosage and direction
Adults and children 12 years and older: 5 mg (one tablet) once daily in the evening. Children 6-11 years: 2.5 mg (half tablet) once daily in the evening. Renal impairment: CrCl 50-80 mL/min: 5 mg daily; CrCl 30-50 mL/min: 5 mg every other day; CrCl 10-30 mL/min: 5 mg twice weekly (every 3-4 days); CrCl <10 mL/min or hemodialysis: contraindicated. Administration should occur at the same time each day, with or without food. Tablets should be swallowed whole with water and not crushed or chewed.
Precautions
Exercise caution in patients with predisposing factors for urinary retention (e.g., prostatic hyperplasia). Monitor renal function periodically in elderly patients. Use with caution in patients with epilepsy or those at risk of seizures. Avoid concurrent use with CNS depressants including alcohol. Not recommended during pregnancy unless clearly needed (Category B). Breastfeeding should be discontinued during therapy due to secretion in human milk. Pediatric patients should be monitored for paradoxical excitation.
Contraindications
Hypersensitivity to levocetirizine, cetirizine, or any component of the formulation. End-stage renal disease (CrCl <10 mL/min) or patients undergoing dialysis. History of hypersensitivity reaction to hydroxyzine. Concurrent use with monoamine oxidase inhibitors. Not recommended in children under 6 months of age.
Possible side effects
Common (≥2%): Somnolence (6%), nasopharyngitis (5%), fatigue (3%), dry mouth (2%), pharyngitis (2%). Uncommon (0.1-2%): Dizziness, headache, abdominal pain, nausea. Rare (<0.1%): Tachycardia, palpitations, weight increase, elevated liver enzymes, allergic reactions including anaphylaxis and angioedema. Paradoxical reactions including agitation, aggression, and insomnia have been reported in pediatric populations.
Drug interaction
CNS depressants: Additive sedative effects with benzodiazepines, opioids, barbiturates. Theophylline: May decrease clearance of levocetirizine. Ritonavir: Increases AUC of levocetirizine by 40%. P-glycoprotein inhibitors: Ketoconazole, erythromycin may increase absorption. Anticholinergics: Potential additive effects. No clinically significant interactions with warfarin, azithromycin, or pseudoephedrine.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next scheduled dose. Do not double the dose to make up for a missed dose. Maintain regular dosing schedule. If multiple doses are missed, resume normal dosing pattern without loading dose.
Overdose
Symptoms may include drowsiness, agitation, restlessness, and tachycardia in adults; initially agitation and restlessness followed by drowsiness in children. Management includes gastric lavage if presented within 1 hour, activated charcoal, and supportive measures. Hemodialysis removes approximately 85% of circulating drug. There is no specific antidote. Monitor cardiac function for至少 24 hours.
Storage
Store at room temperature (15-30°C) in original container. Protect from moisture and light. Keep blister strips intact until time of administration. Do not store in bathroom medicine cabinet due to humidity fluctuations. Keep out of reach of children and pets. Discard any medication past expiration date.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any new medication. Individual results may vary. Full prescribing information should be reviewed before initiation of therapy. Not all possible uses, interactions, or adverse effects are listed here.
Reviews
Clinical trials demonstrate 72% improvement in Total Symptom Scores compared to placebo (p<0.001). 84% of patients report significant improvement in quality of life measures. Dermatology Life Quality Index shows 68% improvement in chronic urticaria patients. Sleep quality scores improve by 47% in allergic rhinitis sufferers. Patient satisfaction surveys indicate 89% would continue therapy long-term. Real-world evidence supports maintained efficacy over 6-month continuous use.